Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Tag: lung infection bacterial
All
Latest
Positive Results for Viromed VAP Therapy
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Read More
$2M NIH Grant to Address Pseudomonas-Linked Lung Infections
Funds from NIH will advance ALX1 as a potential treatment in cystic fibrosis and other chronic lung diseases.
Read More
Virus Infecting Common Bacteria Linked to Accelerated Lung Decline in CF
Cystic fibrosis patients with elevated levels of bacteria infected by Pf phage in their sputum experience a faster decline in lung function.
Read More
Antibiotics During Flu May Increase Risk of Bacterial Pneumonia
Taking antibiotics when sick with the flu might actually backfire, making it more likely for patients to develop serious bacterial pneumonia instead of preventing it, Cedars-Sinai researchers found.
Read More
Pneumonia: Etiology, Care and Prevention
Pneumonia is a potentially life-threatening infection of the lungs that inflames alveoli and spurs the overproduction of purulent material. Typically afflicting neonates and seniors, the COVID pandemic has revealed the importance of proper pneumonia care for all patients.
Read More
FDA Clears Biofire Spotfire Respiratory/Sore Throat Panel Mini
bioMérieux’s Biofire Spotfire Respiratory/Sore Throat (R/ST) Panel Mini received US FDA Special 510(k) clearance and CLIA-waiver, according to the company.
Read More
Jumbo Phage Identified with Potential to Combat CF Lung Infections
Researchers in the United Kingdom have isolated a jumbo phage from wastewater with the potential to fight lung infections caused by Burkholderia cenocepacia.
Read More
Glycan Discovery Holds Promise for Halting Pertussis Transmission
Researchers have identified a new complex-carbohydrate biomolecule, or glycan, that plays a key role in the nasal colonization of the Bordetella bacteria responsible for whooping cough.
Read More
Biofire Spotfire R/ST Panel Gets 510(k) Clearance, CLIA-waiver Approval
bioMérieux received FDA 510(k) clearance and CLIA waiver approval for the Biofire Spotfire Respiratory/Sore Throat (R/ST) Panel.
Read More
Break the TB Chain of Transmission on World TB Day 2024
On World TB Day, 24 March 2024, the Forum of International Respiratory Societies (FIRS) calls on all stakeholders, including multilateral agencies, governments, national and local programs, non-governmental organizations, academics, activists and donors to focus on activities that will break the chain of transmission in high-burden settings in order to end tuberculosis (TB).
Read More
Zinc Manipulation Could Restore Immune Defense in Cystic Fibrosis
University of Queensland researchers have discovered a fault in the bacteria-killing function of immune cells in people with cystic fibrosis and a potential way to get around it.
Read More
Machine Learning Can Predict COVID-19 Bacterial Co-infection Risk
The machine learning technique can help detect whether antibiotic use is critical for patients with these infections.
Read More
Sequential Flu and Measles-like Virus Infections Trigger Deadly Lung Failure
Georgia State University researchers discover that ferrets recovering from flu-like viruses suffer lethal lung damage when subsequently infected with a measles-like virus.
Read More
High Blood Sugar Levels in Diabetics Worsen Lung Infections
Research has revealed how, in diabetics, high levels of blood sugar disrupt the function of key cell subsets in the lungs that regulate the immune response.
Read More
Surgeons Used Breast Implants During Double-Lung Transplant
Northwestern Medicine surgeons removed a 34-year-old’s infected lungs, created an artificial lung to keep him alive, placed breast implants inside the chest cavity to keep the heart in place, and completed a double-lung transplant within 24 hours.
Read More
Metals in Water Linked to Increased Lung Infections in Cystic Fibrosis
An NIH study found high levels of some minerals and metals in environmental water supplies may increase the risk of nontuberculous mycobacteria pulmonary infections in people with cystic fibrosis.
Read More
Investigational 3-month TB Regimen Safe but Ineffective
The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment.
Read More
FDA Clears FebriDx Test to Differentiate Viral and Bacterial Respiratory Infections
The clearance allows FebriDx to be marketed in the United States for use by healthcare professionals as an aid in the diagnosis of bacterial acute respiratory infection and differentiation from non-bacterial etiology in patients presenting in urgent care or emergency care settings.
Read More
Positive Data from Phase 1b/2a Study of Pulmonary Infection Treatment
BiomX has announced positive data from a study assessing the safety and tolerability of BX004 in nine cystic patients.
Read More
Probiotic Significantly Reduced S. aureus Colonization
The probiotic Bacillus subtilis markedly reduced S. aureus colonization in trial participants without harming their gut microbiota.
Read More
Nasal Swab Can Provide Early Warning of Emerging Viruses
Testing for the presence of a single immune system molecule on a nasal swab can help detect stealthy viruses not identified in standard tests.
Read More
Phage Therapy Investigated for Cystic Fibrosis
Enrollment has begun in an early-stage clinical trial evaluating phage therapy (bacteriophage) in adults with cystic fibrosis who carry Pseudomonas aeruginosa in their lungs.
Read More
Cystic Fibrosis: Nebulized Manuka Honey Improved Bacterial Clearance
Combining manuka honey and the drug amikacin in a lab-based nebulization formulation improved bacterial clearance of Mycobacterium abscessus from the lungs of cystic fibrosis patients.
Read More
Cystic Fibrosis: Risk Stratification for CF Patients Listed for Lung Transplants
In patients with cystic fibrosis listed for lung transplantation, a frailty index based on standard multidisciplinary lung transplant assessment data facilitates patient risk stratification.
Read More